Brief: Crescita Therapeutics Announces Approval Of Normal Course Issuer Bid
26/11/2020 12:44
Nov 26 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS ANNOUNCES APPROVAL OF NORMAL COURSE
ISSUER
BID
* CRESCITA THERAPEUTICS - PURSUANT TO NCIB NOTICE FILED WITH
TSX,
INTENDS TO ACQUIRE UP TO A MAXIMUM OF 1 MILLION COMMON SHARES
Source text for Eikon: ID:nCNWhHTHTa
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium